Reference Pricing’s Impact on Biotech Innovation: Weighing the public purse and private investments

12:45 PM - 12:55 PM (EDT), Thursday, June 17, 2021

Duane Schultess will review Vital Transformation’s new research analyzing the impact of H.R. 3 – the “Lower Drug Costs Now” Act – on the development of new medicines and the biotech industry. 

Managing Director
Vital Transformation